Stay updated with breaking news from Pharmatech Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- A groundbreaking study by a team of scientists at YDS Pharmatech, Inc. has introduced an innovative Generative Diffusion Model (GDM) for...
/PRNewswire/ -- YDS Pharmatech, Inc. ("YDS"), today announced that it is presenting at Biotech Showcase™ 2023. YDS is a techbio startup dedicated to building...
Share this article TSX Venture: QPT EDMONTON, AB, June 1, 2021 /PRNewswire/ - Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") announces that clinical investigators working with OncoQuest Pharmaceuticals, Inc. ("OQP") lead clinical candidate oregovomab, will be making two presentations as part of the American Society of Clinical Oncology (ASCO) conference proceedings. OQP acquired oregovomab from OncoQuest Inc., one of the equity investee comp...
‘Vaccine Syringe’ from Poonglim Pharmatech Inc. highly demanded by 20 countries; What special technology hidden in the syringe?
Share: TSX Venture: QPT EDMONTON, AB, Jan. 5, 2021 /CNW/ - Quest PharmaTech Inc. (TSXV:QPT) ("Quest") provides update to its June 4, 2020 news release to announce that one of its equity investee companies, OncoQuest Inc. ("OncoQuest"), completed the transfer of the immunotherapy technology assets to OncoQuest Pharmaceuticals, Inc, a KOSDAQ traded company ("OQP", 078590.KQ) on November 7, 2020. However, due to COVID-19 related Korean courts restrictions, final payment of 65,229,709 shares of OQP to OncoQuest has been delayed by one month from December 31, 2020 to January 31, 2021. In addition,...